Disc Medicine Profit Margin

Disc Medicine (IRON) currently reports a profit margin of 1236.6% as of June 2026. That is above the Healthcare sector average of 14.34%. Use the charts on this page to explore Disc Medicine's profit margin history and peer comparisons.

Disc Medicine's profit margin of 1236.6% is higher than the Healthcare sector average of 14.34%. That is roughly 8520.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Disc Medicine's current 1236.6% should be judged against Healthcare norms (sector average: 14.34%) and against IRON's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 1236.6%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for Disc Medicine, and consider following IRON for alerts when major investors trade the stock.

Disc Medicine is classified in the Healthcare sector. On profit margin, it currently shows 1236.6% versus a sector average near 14.34%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IRON with unrelated industries.